LEADER 05469nam 2200673 450 001 9910140272703321 005 20230803195556.0 010 $a1-118-49402-4 010 $a1-118-49398-2 010 $a1-118-49401-6 035 $a(CKB)2670000000546973 035 $a(EBL)1652083 035 $a(SSID)ssj0001131703 035 $a(PQKBManifestationID)11729001 035 $a(PQKBTitleCode)TC0001131703 035 $a(PQKBWorkID)11142629 035 $a(PQKB)10006575 035 $a(OCoLC)867001329 035 $a(MiAaPQ)EBC1652083 035 $a(DLC) 2013051093 035 $a(Au-PeEL)EBL1652083 035 $a(CaPaEBR)ebr10851659 035 $a(CaONFJC)MIL584452 035 $a(OCoLC)874322105 035 $a(EXLCZ)992670000000546973 100 $a20140408h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAntiplatelet therapy in cardiovascular disease /$fedited by Ron Waksman, Paul A. Gurbel, Michael A. Gaglia, Jr 210 1$aChichester, West Sussex, United Kingdom :$cJohn Wiley & Sons,$d2014. 210 4$d©2014 215 $a1 online resource (349 p.) 300 $aDescription based upon print version of record. 311 $a1-118-27575-6 320 $aIncludes bibliographical references and index. 327 $aAntiplatelet Therapy in Cardiovascular Disease; Copyright; Contents; List of Contributors; Foreword; Preface; Section I Platelet Biology and Pathophysiology; 1 Platelet Pathophysiology and its Role in Thrombosis; Role of platelets during initiation of atherosclerosis and plaque formation; Role of platelets in thrombosis; References; 2 Platelet Receptors and Drug Targets: COX-1; Structure, expression, and catalytic activity of platelet COX-1; Functional role of platelet COX -1; Genetic polymorphisms of COX-1 and COX-2 expression in platelets 327 $aPlatelet COX-1 as a target for antithrombotic therapyInteraction between aspirin and naNSAIDs at the level of platelet COX-1; In vitro and in vivo evidence for aspirin/naNSAID interaction; Concluding remarks; References; 3 Platelet Receptors and Drug Targets: P2Y12; P2 receptors; Roles of adenine nucleotides in platelet function; P2Y12; Conclusions; References; 4 Platelet Receptors and Drug Targets: GP IIb/IIIa; Introduction; Biology of the receptor; Glycoprotein IIb/IIIa receptor in platelet physiology; Platelet aggregation phase; "Inside-out" and "outside-in" GPIIb/IIIa signaling phenomenon 327 $aGlycoprotein IIb/IIIa receptor and thrombus formationGlycoprotein IIb/IIIa receptor antagonists; Intravenous versus oral preparations: clinical aspects; Acknowledgment; References; 5 Platelet Receptors and Drug Targets: PAR1, Collagen, vWF, Thromboxane, and Other Novel Targets; Introduction; Protease-activated receptor 1 (PAR1); References; 6 Role of Inflammation and Hypercoagulability in Thrombosis; References; Section II Platelet Function Tests; 7 Light Transmission Aggregometry; Technique; References; 8 Vasodilator-Stimulated Phosphoprotein (VASP) Assay; Introduction; The VASP index assay 327 $aVASP index and clinical eventsAlteration of antiplatelet therapy based on the VASP index; VASP index and new oral antiplatelet agents; Conclusions; References; 9 VerifyNow P2Y12 and Plateletworks Assays; Introduction; Verifynow P2Y12; Plateletworks; Validity of the test in measuring antiplatelet effect and its association with clinical outcomes; Conclusion; References; 10 Multiplate Analyzer; Historical background; Principles of the Multiplate® analyzer; Advantages; Disadvantages; Clinical studies in cardiovascular medicine; Studies in cardiovascular surgery 327 $aConsensus definitions and cutoff values concerning platelet reactivitySummary; Acknowledgment; References; 11 Shear Stress-Based Platelet Function Tests; PFA-100; IMPACT-R; References; 12 Thrombelastography and Other Novel Techniques; Novel techniques; T2 magnetic resonance (T2MR); Shear-induced platelet aggregation assays; References; Section III Antiplatelet pharmacology; 13 Aspirin; Mode of antiplatelet action; Time dependency of inhibition of platelet function by aspirin; Dose-dependent inhibition of platelet function by aspirin; Negative interactions with other drugs 327 $aPositive interactions with other drugs 330 $a Edited by one of the world's leading interventional cardiologists and educators, this new book is created with an eye on giving the reader a solid, practical and clinically-focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination therapies, drug-drug interactions, and platelet resistance. This important new book: Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how these therapies work and why they can also produce such a varied 606 $aCardiovascular system$xDiseases 606 $aCardiovascular system$xDiseases$xPrevention 615 0$aCardiovascular system$xDiseases. 615 0$aCardiovascular system$xDiseases$xPrevention. 676 $a616.1/061 702 $aWaksman$b Ron 702 $aGurbel$b Paul A. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910140272703321 996 $aAntiplatelet therapy in cardiovascular disease$92184525 997 $aUNINA